Patient P-01684

Synthetic patientNBL-101 · Day 117 · 45–54 · F · baseline S13Steering view · 3D Open companion preview

Therapy response

Stable

Tolerance

Favorable

GI state

Improving

Inflammatory state

Improving

Nutritional resilience

Improving

Discontinuation risk

20%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S13

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Inflammatory activity-9
GI instability-6
Nutritional resilience+4
Treatment adherence-2
Toxicity+2

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

23.5/100

improving · -6.9 vs previous 14 d

Toxicity

Blood

25.5/100

worsening · +5.3 vs previous 14 d

Sleep quality

Wearable

32.2/100

improving · +6.1 vs previous 14 d

Energy level

Daily log

5.4/10

stable · +0.1 vs previous 14 d

Stress level

Daily log

5.4/10

stable · -0.1 vs previous 14 d

Steps

Wearable

9,576

stable · +36 vs previous 14 d

Adherence

Companion

88.5 %

stable · -0.3 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 72 from the failing basin, 20 from restoration.

Good elements to keep

Butyrate producers intact
hidden · steering +7.5
Daily walks resumed
perturbation · steering +3.3

Main detractors to watch

Enterobacteriaceae elevated
hidden · steering -7.4
IL6 high-expression variant
hidden · steering -7.3

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Simple carbohydrates
+0.8no signal · 32%
Alcohol
-0.4no signal · 15%
Dietary fat load
+0.3no signal · 15%
Spicy / capsaicin
-0.3no signal · 15%
Histamine load
+0.1no signal · 15%
Insoluble fibre
+0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Drug metabolism and exposure ↑35
- DNADPYD *2A → slower clearance
Inflammatory signalling ↓25
- DNAIL6 -174 variant raises baseline inflammatory tone
Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
Autonomic recovery ↓20
- WearableShort sleep window
Mucosal barrier integrity ↓10
- WearableSleep 5.9 h, below personal baseline

DNA

Fictional pharmacogenomic panel

IL6 -174 G/C
Higher inflammatory tone
DPYD *2A heterozygous
Slower drug clearance
CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 3.2 · butyrate capacity 54/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiLow
Bacteroides fragilisNormal
Bifidobacterium longumNormal
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 48 ms
Sleep: 6.0 h
Steps: 8,243
Resting HR: 67 bpm

Daily log: GI score 24, nutritional resilience 62, adherence 89.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01571	52%	S13	SC-12	improved	57
P-01804	50%	S19	AD-05	improved	61
P-01430	48%	S05	CR-01	improved	54
P-01724	42%	S10	DT-01	improved	63
P-01342	40%	S11	DT-01	improved	48
P-01346	40%	S12	DT-01	improved	52
P-01593	40%	S10	HY-01	improved	56
P-01752	38%	S20	DT-01	improved	50
P-01455	37%	S01	GI-04	improved	61
P-01861	37%	S12	HY-01	improved	47
P-01555	36%	S06	GI-04	improved	56
P-01374	34%	S08	HY-01	improved	49